Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mu-Opioid Receptor Genetic Polymorphism and the Duration of Intrathecal Fentanyl Labor Analgesia. Mu-Opioid Receptor Genetic Polymorphism and the Efficacy of Postoperative Intrathecal Morphine Analgesia

NCT00418015 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT00418015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00418015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mu-Opioid Receptor Genetic Polymorphism and the Duration of Intrathecal Fentanyl Labor Analgesia. Mu-Opioid Receptor Genetic Polymorphism and the Efficacy of Postoperative Intrathecal Morphine Analgesia
Lead sponsor
Northwestern University
Phase
Observational
Overall status
Completed
Start date
October 31, 2005
Completion date
June 30, 2007
Enrollment
293 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

labor pain, post-cesarean delivery